Use Caution/Monitor.Īcemetacin increases and dobutamine decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.Īceclofenac increases and dobutamine decreases serum potassium. acebutolol decreases effects of dobutamine by pharmacodynamic antagonism. Risk of acute hypertensive episode.Īcebutolol increases and dobutamine decreases serum potassium. Sevoflurane increases toxicity of dobutamine by Mechanism: unknown. Coadministration of ponesimod with drugs that decrease HR may have additive effects on decreasing HR and should generally not be initiated in these patients. Consult cardiologist if considering treatment. Monitor for hypertension with concomitant use.Įither increases effects of the other by pharmacodynamic synergism. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended.

Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Ozanimod increases toxicity of dobutamine by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methoxyflurane increases toxicity of dobutamine by Mechanism: unknown. Isoflurane increases toxicity of dobutamine by Mechanism: unknown. Additive vasospasm risk of hypertension.Įther increases toxicity of dobutamine by Mechanism: unknown. Additive vasospasm risk of hypertension.Įrgotamine, dobutamine. Avoid or Use Alternate Drug.Įrgoloid mesylates, dobutamine.

Additive pressor effect.ĭoxepin, dobutamine. Additive vasospasm risk of hypertension.ĭoxapram increases effects of dobutamine by pharmacodynamic synergism. Additive vasospasm risk of hypertension.ĭihydroergotamine intranasal, dobutamine. Avoid or Use Alternate Drug.ĭihydroergotamine, dobutamine. Risk of V tach, HTN.ĭesipramine, dobutamine. Avoid or Use Alternate Drug.ĭesflurane increases toxicity of dobutamine by Mechanism: unknown. Additive vasospasm risk of hypertension.Ĭlomipramine, dobutamine. Avoid or Use Alternate Drug.Ĭabergoline, dobutamine.

Avoid or Use Alternate Drug.Ĭomment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.Īmoxapine, dobutamine. Risk of acute hypertensive episode.Īmitriptyline, dobutamine. Tranylcypromine increases effects of dobutamine by pharmacodynamic synergism. Selegiline transdermal increases effects of dobutamine by pharmacodynamic synergism. Phenelzine increases effects of dobutamine by pharmacodynamic synergism. Linezolid increases effects of dobutamine by pharmacodynamic synergism. Dose should be titrated so heart rate does not increase by >10% of baseline.Isocarboxazid increases effects of dobutamine by pharmacodynamic synergism. Titrate to patient response (heart rate, presence of ectopic activity, BP, urine output, CVP, PCWP, cardiac index). Administer via infusion pump to ensure precise amount delivered. Rate: Based on patient's weight (see Route/Dosage section).Premixed infusions are already diluted and ready to use. Admixed infusions stable for 48 hr at room temperature and 7 days if refrigerated. Continuous Infusion: Dilution: Vials must be diluted before use.

Dobutamine drip